Liao, R. et al. Studies have shown that the high expression of IL-17 and IL-17RE in tumors was significantly correlated with poor survival rate (p = 0.016 and <0.001, respectively) and increased recurrence rate (all p < 0.001) in patients with HCC(Liao et al., 2013). The gene discussed is IL17A; the disease is hepatocellular carcinoma.